A data breach at Connecticut’s largest healthcare system Yale New Haven Health affects more than 5.5 million people, ...

After a two-year closure, the Yale Center for British Art has reopened with its historical collections in lively conversation ...

The Yale Center for British Art has always been one of the most accessible and comfortable museums to visit in downtown New Haven on street level among boutiques, eateries, coffee shops and ...

A generation of Asian American leaders are finding their own ways to fight for change in New Haven – whether through organization, public service or community-building. Some found their way to Yale ...

NEW HAVEN, Conn. (WTNH ... The iconic pop singer posted to Instagram Thursday, saying she took the train to Yale University to see “Tracey Emin: I Loved You Until The Morning” at the ...

As Brown continues to navigate federal funding threats, Vice President for Research Greg Hirth ScM’87 PhD’91 shared resources — including a new University-wide funding opportunity platform, ...

Yale New Haven (Conn.) Health said that unusual activity affecting its IT systems on March 8 was the result of a data breach. An investigation into the incident revealed that an unauthorized third ...

For more than a hundred years, operating as an academic medical center ‒ or hospital system attached to a university’s medical school ‒ has worked out great for Yale New Haven Health.

GREENVILLE, S.C. (WSPA) – Novant Health announced plans Wednesday to build a new 20-bed hospital on the east side of Greenville. The North Carolina-based healthcare company filed a certificate ...

and around Yale New Haven Hospital. Alders expressed concerns that riders wouldn’t always park the scooters in an upright position, potentially blocking wheelchair access on the sidewalk or simply ...

NEW HAVEN, CT (WFSB) - Two people were killed in ... as 39-year-old Keron Troutman from Hamden. He transported to a hospital where he later died. Both men were found in the street.

Rallybio, a New Haven-based biotechnology firm, said Tuesday it has discontinued development of a therapy intended to prevent a rare immune disorder in fetuses and newborns. The firm’s RLYB212 ...